Lilly, NVIDIA Build AI Supercomputer to Boost Medicine Discovery
New AI capabilities will assist scientists establish, optimize and validate new molecules Additional purposes embody manufacturing, medical imaging and enterprise AI brokers Eli Lilly and Company (NYSE: LLY) at this time introduced it’s constructing probably the most highly effective supercomputer owned and operated by a pharmaceutical firm, in collaboration with NVIDIA. The supercomputer will energy an “AI manufacturing…
